Provided by Tiger Fintech (Singapore) Pte. Ltd.

Krystal Biotech Inc.

132.09
+2.071.59%
Post-market: 132.090.00000.00%19:27 EDT
Volume:354.14K
Turnover:46.39M
Market Cap:3.82B
PE:31.79
High:132.35
Open:130.86
Low:127.99
Close:130.02
Loading ...

Krystal Biotech price target raised to $218 from $212 at Chardan

TIPRANKS
·
20 Feb

High Growth Tech Stocks in United States to Watch

Simply Wall St.
·
20 Feb

Krystal Biotech Price Target Maintained With a $221.00/Share by HC Wainwright & Co.

Dow Jones
·
20 Feb

BUZZ-Krystal Biotech rises after quarterly revenue beat

Reuters
·
19 Feb

Stock Track | Krystal Biotech Soars 5.85% Premarket on Stellar Q4 Results, Pipeline Progress

Stock Track
·
19 Feb

Krystal Biotech Shares Reverse Course From Premarket Loss; Last up 6.2%

THOMSON REUTERS
·
19 Feb

Krystal Biotech Shares Down 4.6% Premarket After Q4 Results

THOMSON REUTERS
·
19 Feb

Krystal Biotech Q4 Net Income, Revenue Rise

MT Newswires Live
·
19 Feb

Krystal Biotech Inc - Q4 EPS$1.52

THOMSON REUTERS
·
19 Feb

Krystal Biotech Inc Q4 Shr View $1.17, REV View $90.5 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
19 Feb

Krystal Biotech Q4 2024 GAAP EPS $1.52 Beats $1.16 Estimate, Sales $91.14M Beat $90.49M Estimate

Benzinga
·
19 Feb

BRIEF-Krystal Biotech Q4 Net Income USD 45.479 Million

Reuters
·
19 Feb

Krystal Biotech Q4 Net Income USD 45.479 Million

THOMSON REUTERS
·
19 Feb

Krystal Biotech Q4 Operating Expenses USD 49.76 Million

THOMSON REUTERS
·
19 Feb

Krystal Biotech Q4 Operating Income USD 41.379 Million

THOMSON REUTERS
·
19 Feb

Krystal Biotech (KRYS) Receives a Buy from Bank of America Securities

TIPRANKS
·
11 Feb

Strength Seen in Ginkgo Bioworks (DNA): Can Its 14.5% Jump Turn into More Strength?

Zacks
·
06 Feb

TD Cowen Sticks to Its Buy Rating for Krystal Biotech (KRYS)

TIPRANKS
·
29 Jan

Is the Options Market Predicting a Spike in Krystal Biotech (KRYS) Stock?

Zacks
·
24 Jan

Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer

THOMSON REUTERS
·
14 Jan